Using B16F10 cells expressing the stable fluorescent protein ZsGreen to enable tracking of antigen acquisition by DCs (Matz et al., 1999), we found a substantial increase in the level of tumor antigen uptake in intratumoral CD103+ DCs within 1 day of AIP treatment compared with untreated or ICB-treated tumors (Figure 2D). This evidence concerns the gene ITGAE and neoplasm.